Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio Tohen

Showing results (141-150 of 260) with videos related to

Pageof 26
Sort By:
Journal of Clinical Psychopharmacology|March 18, 2003
Acute dysphoric mania: treatment response to olanzapine versus placeboRobert W Baker, Mauricio Tohen, Jan Fawcett, et al.
Journal of Affective Disorders|August 13, 2014
Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disordersJoseph R Calabrese, Maurizio Fava, George Garibaldi, et al.
Archives of General Psychiatry|April 3, 2002
Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophreniaRobert W McCarley, Dean F Salisbury, Yoshio Hirayasu, et al.
European Child & Adolescent Psychiatry|June 3, 2015
Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trialMarie Stentebjerg-Olesen, Stephen J Ganocy, Robert L Findling, et al.
Psychological Medicine|June 3, 2006
Insight in first-episode psychosisJoseph P McEvoy, Jackie Johnson, Diana Perkins, et al.
The Journal of Clinical Psychiatry|September 19, 2017
Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled TrialLe Xiao, Stephen J Ganocy, Robert L Findling, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2004
Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disordersDiana Perkins, Jeffrey Lieberman, Hongbin Gu, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 6, 2008
Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trialLudmila Kryzhanovskaya, S Charles Schulz, Christopher McDougle, et al.
Journal of Affective Disorders|January 1, 2003
Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cyclingTodd M Sanger, Mauricio Tohen, Eduard Vieta, et al.
Psychiatric Services (Washington, D.C.)|August 9, 2023
The Cascade of Care for Early Psychosis Detection in a College Counseling CenterJustine L Saavedra, Annette Crisanti, David T Lardier, et al.
Pageof 26

Showing results (141-150 of 260) with videos related to

Sort By:
Pageof 26
Journal of Clinical Psychopharmacology|March 18, 2003
Acute dysphoric mania: treatment response to olanzapine versus placeboRobert W Baker, Mauricio Tohen, Jan Fawcett, et al.
Journal of Affective Disorders|August 13, 2014
Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disordersJoseph R Calabrese, Maurizio Fava, George Garibaldi, et al.
Archives of General Psychiatry|April 3, 2002
Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophreniaRobert W McCarley, Dean F Salisbury, Yoshio Hirayasu, et al.
European Child & Adolescent Psychiatry|June 3, 2015
Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trialMarie Stentebjerg-Olesen, Stephen J Ganocy, Robert L Findling, et al.
Psychological Medicine|June 3, 2006
Insight in first-episode psychosisJoseph P McEvoy, Jackie Johnson, Diana Perkins, et al.
The Journal of Clinical Psychiatry|September 19, 2017
Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled TrialLe Xiao, Stephen J Ganocy, Robert L Findling, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2004
Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disordersDiana Perkins, Jeffrey Lieberman, Hongbin Gu, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 6, 2008
Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trialLudmila Kryzhanovskaya, S Charles Schulz, Christopher McDougle, et al.
Journal of Affective Disorders|January 1, 2003
Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cyclingTodd M Sanger, Mauricio Tohen, Eduard Vieta, et al.
Psychiatric Services (Washington, D.C.)|August 9, 2023
The Cascade of Care for Early Psychosis Detection in a College Counseling CenterJustine L Saavedra, Annette Crisanti, David T Lardier, et al.
Pageof 26